摘要
目的探究慢阻肺急性加重期患者采用糖皮质激素联合特布他林治疗的临床疗效。方法选取该院收治的104例慢阻肺急性加重期患者为研究对象,按照治疗方法的不同将其分为实验组(特布他林+糖皮质激素治疗)和对照组(特布他林治疗),观察两组的治疗效果。结果两组患者经治疗后总有效率比较χ2=25.858 8(P=0.000 0),总不良反应率比较χ2=11.906 0(P=0.000 6),差异有统计学意义(P<0.05)。结论糖皮质激素联合特布他林治疗急性加重期慢阻肺疾病临床效果确切,不良反应少,安全性高,值得临床应用以及推广。
Objective To explore the clinical curative effect of glucocorticoid plus terbutaline on patients with chronic obstructive pulmonary disease（COPD） in acute exacerbation. Methods 104 patients with COPD in acute exacerbation admitted in our hospital were selected as the subjects, and divided into the experimental group treated by terbutaline plus glucocorticoid and the control group treated by terbutaline. And the treatment effect of the two groups was observed. Results After treatment, comparing the total effective rate between the two groups of patients, χ^2=25.858 8（P=0.000 0）, comparing the total adverse reactions between the groups,χ^2=11.906 0（P=0.000 6）, P〈0.05, the differences were statistically significant. Conclusion Glucocorticoid combined with terbutaline in the treatment of chronic obstructive pulmonary disease in acute exacerbation has exact clinical effect with less adverse reactions and high safety, which is worthy of clinical application and promotion.
出处
《中外医疗》
2014年第26期1-2,共2页
China & Foreign Medical Treatment
关键词
慢阻肺
急性加重期
糖皮质激素
特布他林
Chronic obstructive pulmonary disease
Acute exacerbation
Glucocorticoid
Terbutaline
